[The kaolin-activated recalcification test in the screening of coagulation disorders and in the control of anticoagulant therapy].
The AA. have standardized a method for determining the kaolin activated plasma recalcification time (TRA) and have fixed its normal range between 33 and 60 seconds (average +/- 3 DS) testing 2000 normal subjects. By this method they have been able to demonstrate that TRA is more sensitive than PTT during the haemorrhagic manifestations in thrombocytopenic patients and in monitoring heparin therapy, while it shows a behaviour similar to PTT in detecting coagulation defects. It has also been found that TRA had remarkably increased its values in thrombocytopatic non thrombocytopenic patients, when PTT was normal. TRA does not seem to be useful in coumarin or indanedione therapy, since its values are constantly but not proportionally increased only when prothromsitive than PTT during the haemorrhagic manifestations in thrombocytopenic pabin time is very prolonged. Finally TRA can advantageusly substitute the whole blood clotting time and the non activated recalcification time for its easy performance, remarkable precision and low cost.
D000925:Anticoagulants / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000175:diagnosis* / Q000188:drug therapy; D001780:Blood Coagulation Tests; D001791:Blood Platelet Disorders / Q000175:diagnosis; D005260:Female; D006801:Humans; D007616:Kaolin / Q000627:therapeutic use*; D008297:Male
D000925:Anticoagulants; D007616:Kaolin
Il test di ricalcificazione attivato con caolino nello screening delle coagulopatie e nel controllo delle terapie anticoagulanti.